About 1 results

Emory University scientists collaborated with scientists from the Walter Reed Army Institute of Research (WRAIR) to measure the plasmablast response induced in human subjects following administration of two candidate dengue vaccines. Researchers first vaccinated with a live-attenuated dengue vaccine and then "boosted" with a purified inactivated dengue vaccine. WRAIR and GlaxoSmithKline (GSK) co-developed both of these candidate vaccines.